Effect of Doxorubicin Release Rate From Polyethylene Glycol-Modified Liposome on Anti-tumor Activity in B16-BL6 Tumor-Bearing Mice

This publication has 30 references indexed in Scilit:

• PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy
  International Journal of Pharmaceutics, 2011
• Delivering nanomedicine to solid tumors
  Nature Reviews Clinical Oncology, 2010
• Targeted delivery of doxorubicin using stealth liposomes modified with transferrin
  International Journal of Pharmaceutics, 2009
• Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: Importance of vascular permeability within tumors
  International Journal of Pharmaceutics, 2008
• Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors
  Clinical Cancer Research, 2005
• Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
  Journal of Controlled Release, 2005
• Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
  Science, 2005
• Tumor necrosis factor‐α augmented tumor response in B16BL6 melanoma‐bearing mice treated with stealth liposomal doxorubicin (Doxil®) correlates with altered Doxil® pharmacokinetics
  International Journal of Cancer, 2004
• Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
  FEBS Letters, 1990
• Diffusion of univalent ions across the lamellae of swollen phospholipids
  Journal of Molecular Biology, 1965